NDC 0228-3153 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC0228-3153

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Actavis Pharma, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA090819
Marketed since
February 19, 2015
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (1)

Package NDCDescriptionSince
0228-3153-0330 TABLET in 1 BOTTLE (0228-3153-03)Apr 10, 2015

Other Buprenorphine products